MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: How vision sends its message to the brain

Back to ophthalmology news Blogs list Cancer blog  


Subscribe To Ophthalmology News RSS Feed  RSS content feed What is RSS feed?

How vision sends its message to the brain




Researchers have known for more than 200 years that vision begins with a series of chemical reactions when light strikes the retina, but the specific chemical processes have largely been a mystery. A team of scientists from the United States and Switzerland, have she new light on this process by "capturing" this chemical communication for future study. This research, reported in the February 2009 issue of The FASEB Journal (http://www.fasebj.org), may lead to the development of new therapys for some forms of blindness and vision disorders.



How vision sends its message to the brain

At the center of the discovery is the signaling of rhodopsin to transducin. Rhodopsin is a pigment in the eye that helps detect light. Transducin is a protein (sometimes called "GPCR") which ultimately signals the brain that light is present. The scientists were able to "freeze frame" the chemical communication between rhodopsin and transducin to study how this takes place and what goes wrong at the molecular level in certain disorders.

As per Krzysztof Palczewski, a senior scientist involved in the research, "The results may have important implications for discovery and development of more specific medicines to treat GPCR-linked dysfunction and disease." Examples of health problems involving GPCR dysfunction include blindness, diabetes, allergies, depression, cardiovascular defects and some forms of cancer.

To make their discovery, researchers isolated rhodopsin/transducin directly from bovine retinas. These membranes were suspended in solution and exposed to light to start the chemical signaling process. After light exposure, any contaminating proteins were removed, and the remaining rhodopsin and transducin "locked" in their chemical communication were removed using a centrifuge. In addition to helping researchers understand how vision begins, this research may also impact disorders affecting heart beat, blood pressure, memory, pain sensation, and infection response because it is believed that they are regulated by similar chemical communications involving similar proteins.

"Until now, researchers have been in the dark when it comes to exactly how vision begins. This exciting new work shows how light becomes a chemical signal to the brain," said Gerald Weissmann, Editor-in-Chief of The FASEB Journal "Now that we see the light, so to speak, entirely new types of custom-fit become possible for a wide range of diseases".


Posted by: Mike    Source




Did you know?
Researchers have known for more than 200 years that vision begins with a series of chemical reactions when light strikes the retina, but the specific chemical processes have largely been a mystery. A team of scientists from the United States and Switzerland, have she new light on this process by "capturing" this chemical communication for future study. This research, reported in the February 2009 issue of The FASEB Journal (http://www.fasebj.org), may lead to the development of new therapys for some forms of blindness and vision disorders.

Medicineworld.org: How vision sends its message to the brain

Cancer terms| History of cancer| Imaging techniques| Cancer Main| Bladder cancer news| Cervix cancer news| Colon cancer news| Esophageal cancer news| Gastric cancer news| Health news| Lung cancer news| Breast cancer news| Ovarian cancer news| Cancer news| Pancreatic cancer news| Prostate cancer news| Endometrial cancer news| General info| What is cancer?| Cancer causes| Is cancer hereditary?| Types of cancer| Cancer statistics| Breast cancer main| Breast cancer symptoms| Colon cancer main| Anal cancer| Bladder cancer main| Lung cancer general| Lung cancer main| Non small cell| Small cell| Ovarian cancer main| Treatment of ovarian cancer| Prostate cancer main| Updates in oncology| Acute myeloid leukemia|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.